Featuring Myasthenia Gravis News/ BioNews

MGFA has partnered with Bionews to feature the Myasthenia Gravis News feed on our website, providing the community with research updates, disease management insights, and relevant news. All content is original and produced by Bionews’ editorial staff, and perspectives from patients and caregivers. Information is not meant to replace or provide medical advice.

Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News

  • Honoring those who care for others by ensuring no one is forgotten
    by Mark Harrington on March 18, 2026 at 2:00 pm

    Turn on the news almost any day, and it can feel as if the moral temperature of the country has dropped a few degrees. Stories of violence, greed, callousness, and unspeakable crimes dominate the headlines. It can be easy to develop a dark outlook about the world and the people who inhabit it. For those The post Honoring those who care for others by ensuring no one is forgotten appeared first on Myasthenia Gravis News.

  • Thymectomy eases symptoms for children, teens with juvenile MG
    by Andrea Lobo on March 18, 2026 at 1:00 pm

    Surgical removal of the thymus, or thymectomy, significantly improves nerve-muscle communication and eases symptoms and their impact on daily activities in children and adolescents with juvenile myasthenia gravis (JMG), a small U.S. study showed. After thymectomy, young patients not only showed measurable improvements in how efficiently their nerves activated an eye muscle commonly affected in The post Thymectomy eases symptoms for children, teens with juvenile MG appeared first on Myasthenia Gravis News.

  • Family history and myasthenia gravis: Is there a connection?
    by Agata Boxe on March 18, 2026 at 11:00 am

    Living with myasthenia gravis (MG) can make you wonder why you developed the disease and whether you can pass it on to your children. It’s natural to have these questions, especially when you’re planning a family. You may find it reassuring to know that the condition is not considered hereditary and that it’s rare for The post Family history and myasthenia gravis: Is there a connection? appeared first on Myasthenia Gravis News.

  • Real-world study finds Vyvgart often effective in gMG, but responses vary
    by Margarida Maia, PhD on March 17, 2026 at 12:00 pm

    In real-world practice, Vyvgart (efgartigimod alfa) is generally well tolerated and often effective for adults with generalized myasthenia gravis (gMG) who are positive for antibodies against the acetylcholine receptor (AChR) protein, a study showed. However, responses vary across patients and are often not durable, data showed. “These findings highlight the heterogeneity [variability] of therapeutic outcomes and The post Real-world study finds Vyvgart often effective in gMG, but responses vary appeared first on Myasthenia Gravis News.

  • The traitor within: Navigating the internal triggers of myasthenia gravis
    by Shawna Barnes on March 16, 2026 at 2:00 pm

    Living with myasthenia gravis (MG) means learning that not all triggers come from the outside world. Some of the biggest ones come from inside my own body, the traitor. Hormonal shifts, sleep disruptions, and internal rhythms can shape my symptoms long before I’m aware danger is afoot. These triggers tend to be quieter than heat, The post The traitor within: Navigating the internal triggers of myasthenia gravis appeared first on Myasthenia Gravis News.

** MGFA Disclaimer – Please read

Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.

The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.

Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.

Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.

Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.

The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.